Array Firms Debut New Products to Cash in on 'Lucrative' Sequence-Capture Market
July 14, 2009
Array Firms Debut New Products to Cash in on 'Lucrative' Sequence-Capture Market
Agilent Technologies and Febit this week separately announced expansions to their sequence capture product lines, while Roche NimbleGen discussed plans to grow its seq-cap portfolio by year end.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Roche to Phase out Chip-Based Sequence Capture; Peptide Arrays 'Close' to Commercialization
October 2, 2012 / BioArray News - Eli Lilly Taps SeqWright to Use Roche NimbleGen and 454 Tools in Psychiatric Diseases Study
August 4, 2009 / BioArray News - Agilent Secures First On-array Sequence Capture IP, But Market Impact is Unclear
March 15, 2011 / BioArray News - NimbleGen Array Capture Outperforms Two Target-Enrichment Methods in ABRF Research Group Comparison
April 6, 2010 / In Sequence - Agilent Snags Life Technologies as Latest Co-Marketing Partner for SureSelect Target-Enrichment System
September 22, 2009 / BioArray News